These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18614790)

  • 21. VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management.
    Izzedine H; Massard C; Spano JP; Goldwasser F; Khayat D; Soria JC
    Eur J Cancer; 2010 Jan; 46(2):439-48. PubMed ID: 20006922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombotic microangiopathy in the early post-renal transplant period.
    Ardalan MR; Shoja MM; Tubbs RS; Etemadi J; Esmaili H; Khosroshahi HT
    Ren Fail; 2008; 30(2):199-203. PubMed ID: 18300121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare case of renal thrombotic microangiopathy associated with Castleman's disease.
    Mutneja A; Cossey LN; Liapis H; Chen YM
    BMC Nephrol; 2017 Feb; 18(1):57. PubMed ID: 28183278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth.
    Liang XB; Ma LJ; Naito T; Wang Y; Madaio M; Zent R; Pozzi A; Fogo AB
    J Am Soc Nephrol; 2006 Jul; 17(7):1886-95. PubMed ID: 16790514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier.
    Eremina V; Baelde HJ; Quaggin SE
    Nephron Physiol; 2007; 106(2):p32-7. PubMed ID: 17570946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes.
    Foster RR; Hole R; Anderson K; Satchell SC; Coward RJ; Mathieson PW; Gillatt DA; Saleem MA; Bates DO; Harper SJ
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1263-73. PubMed ID: 12620928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.
    Müller-Deile J; Worthmann K; Saleem M; Tossidou I; Haller H; Schiffer M
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1656-67. PubMed ID: 19828679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of thyroid state on cardiac and renal capillary density and glomerular morphology in rats.
    Rodríguez-Gómez I; Banegas I; Wangensteen R; Quesada A; Jiménez R; Gómez-Morales M; O'Valle F; Duarte J; Vargas F
    J Endocrinol; 2013 Jan; 216(1):43-51. PubMed ID: 23048210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy.
    Erpenbeck L; Demers M; Zsengellér ZK; Gallant M; Cifuni SM; Stillman IE; Karumanchi SA; Wagner DD
    J Am Soc Nephrol; 2016 Jan; 27(1):120-31. PubMed ID: 26038528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine A(2B) receptor mediates an increase on VEGF-A production in rat kidney glomeruli.
    Valladares D; Quezada C; Montecinos P; Concha II; Yañez AJ; Sobrevia L; San Martín R
    Biochem Biophys Res Commun; 2008 Feb; 366(1):180-5. PubMed ID: 18060864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
    Lee EY; Shim MS; Kim MJ; Hong SY; Shin YG; Chung CH
    Exp Mol Med; 2004 Feb; 36(1):65-70. PubMed ID: 15031673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombotic microangiopathy after simultaneous pancreas-kidney transplantation.
    Rangel EB; Gonzalez AM; Linhares MM; Araújo SR; Franco MF; de Sá JR; Pestana JO; Melaragno CS
    Clin Transplant; 2007; 21(2):241-5. PubMed ID: 17425752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of adriamycin on cultured mouse podocytes VEGF expressions and the potential protective effects of dexamethasone].
    Li XZ; Yuan HT; Zhang XG
    Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):146. PubMed ID: 14759327
    [No Abstract]   [Full Text] [Related]  

  • 34. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
    Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of thrombotic complications of old and new anticancer drugs.
    Levi M; Sivapalaratnam S
    Thromb Res; 2020 Jul; 191 Suppl 1():S17-S21. PubMed ID: 32736772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor.
    Uchida K; Uchida S; Nitta K; Yumura W; Marumo F; Nihei H
    Am J Physiol; 1994 Jan; 266(1 Pt 2):F81-8. PubMed ID: 8304487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular endothelial cell differentiation.
    Ballermann BJ
    Kidney Int; 2005 May; 67(5):1668-71. PubMed ID: 15840009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplantation proteinuria and sirolimus.
    Izzedine H; Brocheriou I; Frances C
    N Engl J Med; 2005 Nov; 353(19):2088-9. PubMed ID: 16282189
    [No Abstract]   [Full Text] [Related]  

  • 39. Biology of anti-angiogenic therapy-induced thrombotic microangiopathy.
    Eremina V; Quaggin SE
    Semin Nephrol; 2010 Nov; 30(6):582-90. PubMed ID: 21146123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.